Xingnaojing for Mild-to-severe Acute Ischemic Stroke
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Acute Ischemic Stroke
- Stroke Acute
- Stroke Ischemic
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Both males and females
Description
The XMAS-2 study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. The primary hypothesis of this trial is that Xingnaojing will improve the daily living ability of acute ischemic stroke at 90 days. Xingnaojing will be compared to placebo, combined with guidelines-based ...
The XMAS-2 study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. The primary hypothesis of this trial is that Xingnaojing will improve the daily living ability of acute ischemic stroke at 90 days. Xingnaojing will be compared to placebo, combined with guidelines-based standard care in patients with acute ischemic stroke within 24 hours of symptom onset. All participants will have a National Institutes of Health Stroke Scale(NIHSS)entry score of 4-25. Participants who have planned or already received the intravenous thrombolysis or endovascular treatment will be excluded. The primary outcome will be determined at 90 days.
Tracking Information
- NCT #
- NCT04150835
- Collaborators
- Beijing Shuyi Hospital
- Peking University Third Hospital
- The Airport Hospital of Shunyi District Beijing
- Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine
- Hubei Hospital of Traditional Chinese Medicine
- The First Hospital of Jilin University
- The Affiliated Hospital of Liaoning University of TCM
- Guangzhou Hospital of Traditional Chinese Medicine
- The Third Affiliated Hospital of Shenzhen University
- Anshan Central Hospital
- The Second People's Hospital of Anhui Province
- The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
- The NO.4 People's Hospital of Hengshui
- The Second Hospital of Hebei Medical University
- Zhejiang Provincial Hospital of TCM
- The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
- Zhejiang Provincial Tongde Hospital
- Second Affiliated Hospital of Wenzhou Medical University
- The Third Hospital of Xi'an City
- The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine
- The Affiliated Hospital of Shaanxi University of Chinese Medicine
- Shandong University of Traditional Chinese Medicine
- The First Affiliated Hospital of Guizhou University of TCM
- The First Hospital of Qiqihar City
- Taizhou Hospital of Traditional Chinese Medicine
- Tianshui Hospital of Traditional Chinese Medicine
- Hunan Academy of Traditional Chinese Medicine Affiliated Hospital
- The First Affiliated Hospital of Guangxi University of Chinese Medicine
- The third people's Hospital of Hubei Province
- Yantai Yuhuangding Hospital
- The Affiliated Hospital of Changzhi Academy of TCM
- Liling Hospital of Traditional Chinese Medicine
- People's Hospital of Quzhou
- Haikou People's Hospital
- Zibo Hospital of Traditional Chinese Medicine
- Longhua Hospital
- Investigators
- Principal Investigator: Ying Gao, MD Dongzhimen Hospital
Get Well Soon